[REVISION HISTORY]
Alzheimer's disease research and therapeutic developments
Updated 1 time since CLSTR started tracking revisions of this situation.
What changed
2026-08-26 21:19 UTC → 2026-08-26 21:37 UTC ·
added
removed
Scientific research into Alzheimer’s disease has focused on various biological mechanisms and the efficacy of different therapeutic approaches. Investigations have explored the possibility that the disease could spread through infection-like mechanisms, specifically examining whether amyloid-beta proteins might be transmitted via medical procedures such as blood transfusions. Studies have also A review published in The Lancet has examined the hypothesis that amyloid-beta proteins might behave similarly to infectious pathogens. This follows a 2023 study from Denmark and Sweden involving over one million people, which found that recipients of blood from donors who later developed cerebral hemorrhages faced a higher risk of similar brain bleeds years later. This risk is linked to cerebral amyloid angiopathy, a condition associated with amyloid-beta proteins. While the presence of amyloid-beta ‘seeds’ in the blood is considered a biologically plausible explanation, experts emphasize that there is currently insufficient evidence to prove that blood transfusions are a common route of transmission or that the disease is contagious. Neurologists note that while research is vital for ensuring transfusion safety, further studies are required to establish a causal relationship. Other research has identified potential preventative measures and treatment challenges. Research Studies involving postmenopausal women in the United Kingdom suggests suggest that hormone replacement therapy (HRT) may reduce the risk of dementia and Alzheimer’s. Concurrently, researchers have identified gaps in current treatment protocols. Studies indicate protocols, noting that patients presenting with atypical symptoms—such as impairments in language or vision rather than memory—may vision—may be excluded from eligibility for existing anti-amyloid therapies. Additionally, neuroscientific findings have highlighted the role of the Neurofilament Light Chain (NEFL) protein, suggesting that reducing its levels could improve cognitive and motor functions.
Versions
- 2026-08-26 21:37 UTC Alzheimer's disease research and therapeutic developments
- 2026-08-26 21:19 UTC Alzheimer's disease research and therapeutic developments
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.